Positive list system baffles drug makers

Published: 2008-03-12 06:59:00

Updated: 2008-03-12 06:59:00

Concerns are mounting among drug makers over the so-called positive list system that may affect their export drive of generic drugs, although they are spending huge investments to construct or upgrade their GMP (good manufacturing practices) facilities.

Following the ratification of free trade...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK